Back to results
US 2013/0157880 A1Published application
Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
AssigneeSanofi
InventorsMathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of identifying a compound involved in pain, the use of Car3 nucleic acid or Car3 protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
Claims17
A method of identifying a compound involved in pain, the method comprising the steps of:
- a) providing a test system comprising Car3 nucleic acid or Car3 protein or a functionally active variant of Car3 protein,
- b) contacting the test system with a test compound, and
- c) determining the effect of the test compound on the test system,
- wherein the test compound is identified as a compound involved in pain when a significant effect of the test compound on the test system relative to a control is detected.
1 more element
(canceled)
12-14. (canceled)
A method of diagnosing algesia, comprising the steps of
- a) determining the level of expression of the Car3 gene in a subject's sample, and
- b) identifying the subject as algesic if the level expression of the Car3 gene is increased in the subject's sample relative to a control sample.
Dependencies are inferred from the claim text.